Drugs / [F-18]W372
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT00954369 | Aug 2009 → Feb 2010 | Alzheimer disease | Siemens Molecular Imaging | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [F-18]W372 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00954369 ↗ |
| Modality | Diagnostic / imaging agent | “being developed as a diagnostic radiopharmaceutical for PET imaging of the human brain” NCT00954369 ↗ |